DOLLAR VOLUME OF HEALTH CARE MERGERS AND ACQUISITIONS DOUBLES IN THE SECOND QUARTER OF 2012, ACCORDING TO NEW REPORT FROM IRVING LEVIN ASSOCIATES, INC.
FOR IMMEDIATE RELEASE Stephen M. Monroe, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – July 19, 2012– The dollar volume of merger and acquisition activity in the health care industry more than doubled in the...Health Care Deal News: Spotlight on E-Health- July 2012
The e-health market continues to be very active, with 10 transactions announced in June alone and well over 50 for the first six months of 2012. In the largest announced acquisition in June, Lightyear Capital, a private equity firm with approximately $3 billion of...The Health Care M&A Monthly: Amylin Gets Bid Up
Bristol-Myers Squibb Finishes What It Started In February Hindsight always helps, but it looks like the board of Amylin (NASDAQ: AMLN) had it right when they rejected the unsolicited bid from Bristol-Myers Squibb (NYSE: BMY) last February for $22.00 per share. It was...Health Care Deal News- July 9, 2012
Brought to you by www.DealSearchOnline.com July 9, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Long-Term Care Spotlight on: Biotechnology Conference Calendar Recent Health Care M&A Deals BIOTECHNOLOGY Acquirer Target Price Vitrolife Cryo...Health Care Deal News: Spotlight on Biotechnology- June 2012
Abbott Laboratories (NYSE: ABT) is entering into an agreement with Action Pharma A/S to develop and commercialize Action’s AP214, a compound to prevent acute kidney injury associated with major cardiac surgery. Under terms of the deal, ABT will pay Action, a company...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
